EW (STOCKS)
Edwards Lifesciences Corp
$92.560000
-0.490000 (-0.53%)
Prev close: $93.050000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Bernard J. Zovighian
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $55,883.37M
- Employees
- 15,800
- P/E (TTM)
- 55.22
- P/B (TTM)
- 5.05
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
13
Strong Buy
17
Buy
10
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.78 | $0.76 | +0.0173 | +2.27% |
|
Mar 2026 (Q1)
|
$0.78 | $0.75 | +0.0312 | +4.17% |
|
Dec 2025 (Q4)
|
$0.58 | $0.64 | -0.0563 | -8.85% |
|
Sep 2025 (Q3)
|
$0.67 | $0.61 | +0.0588 | +9.62% |
Financial Statements
| Revenues | $6.51B |
| Benefits Costs and Expenses | $5.09B |
| Cost Of Revenue | $1.44B |
| Costs And Expenses | $5.09B |
| Gross Profit | $5.07B |
| Nonoperating Income/Loss | -$31.40M |
| Operating Expenses | $3.62B |
| Selling, General, and Administrative Expenses | $2.20B |
| Research and Development | $1.09B |
| Other Operating Expenses | $328.60M |
| Operating Income/Loss | $1.45B |
| Income/Loss From Continuing Operations After Tax | $978.60M |
| Income/Loss From Continuing Operations Before Tax | $1.42B |
| Income/Loss From Discontinued Operations Net Of Tax | $25.00M |
| Income Tax Expense/Benefit | $439.00M |
| Interest Income/Expense After Provision For Losses | -$30.80M |
| Interest Income/Expense Operating, Net | -$30.80M |
| Net Income/Loss | $1.00B |
| Net Income/Loss Attributable To Noncontrolling Interest | -$1.30M |
| Net Income/Loss Attributable To Parent | $1.00B |
| Net Income/Loss Available To Common Stockholders, Basic | $1.00B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | $1.74 |
| Diluted Earnings Per Share | $1.74 |
| Basic Average Shares | 1,738,900,000 |
| Diluted Average Shares | 1,742,600,000 |
| Assets | $13.87B |
| Current Assets | $6.82B |
| Inventory | $1.13B |
| Prepaid Expenses | $119.00M |
| Other Current Assets | $5.57B |
| Noncurrent Assets | $7.05B |
| Fixed Assets | $1.84B |
| Intangible Assets | $1.38B |
| Other Non-current Assets | $3.82B |
| Liabilities | $3.14B |
| Current Liabilities | $1.51B |
| Accounts Payable | $210.50M |
| Wages | $372.90M |
| Other Current Liabilities | $924.50M |
| Noncurrent Liabilities | $1.63B |
| Equity | $10.72B |
| Equity Attributable To Noncontrolling Interest | $106.90M |
| Equity Attributable To Parent | $10.62B |
| Liabilities And Equity | $13.87B |
| Net Cash Flow From Operating Activities | $1.72B |
| Net Cash Flow From Operating Activities, Continuing | $1.72B |
| Net Cash Flow From Investing Activities | -$912.10M |
| Net Cash Flow From Investing Activities, Continuing | -$912.10M |
| Net Cash Flow From Financing Activities | -$1.20B |
| Net Cash Flow From Financing Activities, Continuing | -$1.20B |
| Exchange Gains/Losses | $14.50M |
| Net Cash Flow | -$380.30M |
| Net Cash Flow, Continuing | -$394.80M |
| Comprehensive Income/Loss | $1.05B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$6.30M |
| Comprehensive Income/Loss Attributable To Parent | $1.06B |
| Other Comprehensive Income/Loss | $49.50M |
| Other Comprehensive Income/Loss Attributable To Parent | $44.50M |